ANDA 214082, held by Dr Reddys Labs SA. Cysteine Hydrochloride.
As of Nov 16, 2026, ANDA 214082 (Cysteine Hydrochloride), held by Dr Reddys Labs SA, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 1, 2023 | Original application | Tentative approval |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cysteine Hydrochloride500MG/10ML (50MG/ML) ยท solution;intravenous | Cysteine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters